Medigen Vaccine Biologics (6547) — Net Asset Quality Index
Medigen Vaccine Biologics (6547) has a Net Asset Quality Index of 88.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$3.93 Billion minus total liabilities of NT$454.64 Million yields net assets of NT$3.48 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Medigen Vaccine Biologics liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Medigen Vaccine Biologics Net Asset Quality Index Over Time (2012–2025)
This chart shows how Medigen Vaccine Biologics's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the index stands at 88.4%, representing net assets of NT$3.48 Billion against total assets of NT$3.93 Billion TWD. Explore Medigen Vaccine Biologics (6547) cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Medigen Vaccine Biologics (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Medigen Vaccine Biologics from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 6547 market cap overview.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.4% | NT$3.48 Billion | NT$3.93 Billion | NT$454.64 Million | ▲ +0.2 pp |
| 2024 | 88.2% | NT$3.85 Billion | NT$4.36 Billion | NT$513.92 Million | ▲ +25.1 pp |
| 2023 | 63.1% | NT$3.85 Billion | NT$6.09 Billion | NT$2.25 Billion | ▼ -5.3 pp |
| 2022 | 68.4% | NT$5.03 Billion | NT$7.35 Billion | NT$2.32 Billion | ▼ -19.8 pp |
| 2021 | 88.2% | NT$4.68 Billion | NT$5.30 Billion | NT$622.95 Million | ▼ -1.7 pp |
| 2020 | 90.0% | NT$3.14 Billion | NT$3.49 Billion | NT$349.40 Million | ▲ +30.0 pp |
| 2019 | 60.0% | NT$1.37 Billion | NT$2.28 Billion | NT$910.28 Million | ▼ -13.8 pp |
| 2018 | 73.8% | NT$1.61 Billion | NT$2.18 Billion | NT$571.10 Million | ▲ +2.6 pp |
| 2017 | 71.2% | NT$1.52 Billion | NT$2.14 Billion | NT$615.41 Million | ▼ -9.7 pp |
| 2016 | 80.9% | NT$1.47 Billion | NT$1.82 Billion | NT$347.90 Million | ▼ -0.4 pp |
| 2015 | 81.3% | NT$1.34 Billion | NT$1.65 Billion | NT$309.19 Million | ▼ -7.5 pp |
| 2014 | 88.8% | NT$1.08 Billion | NT$1.21 Billion | NT$135.95 Million | ▼ -7.1 pp |
| 2013 | 95.9% | NT$457.94 Million | NT$477.40 Million | NT$19.46 Million | ▲ +10.7 pp |
| 2012 | 85.2% | NT$128.00 Million | NT$150.15 Million | NT$22.15 Million | — |